Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Monitoring luminAl Breast Cancer Through the Evaluation of Mutational and epiGeNEtic alteraTIons of Circulating ESR1 DNA

NCT05814224 is registered in ClinicalTrials.gov with Centro di Riferimento Oncologico - Aviano as lead sponsor.

NCT NCT05814224
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05814224 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Monitoring luminAl Breast Cancer Through the Evaluation of Mutational and epiGeNEtic alteraTIons of Circulating ESR1 DNA
Lead sponsor
Centro di Riferimento Oncologico - Aviano
Phase
Not applicable
Overall status
Unknown status
Start date
May 22, 2018
Completion date
December 31, 2024
Enrollment
164 (estimated)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

antineoplastic agents, aromatase inhibitors, breast diseases, breast neoplasms, esr1 gene mutation, hormone receptor positive breast carcinoma, neoplasms, breast